세계 자궁경 검사 기기 시장 규모는 2023년 12억 9,000만 달러, 2030년까지 21억 3,000만 달러에 달할 것으로 예상되며, 2024-2030년 예측 기간 동안 연평균 7.40%의 성장률을 보일 것으로 예상됩니다. 자궁경 검사 기기에 대한 수요 증가는 주로 부인과 질환의 증가와 전 세계적으로 노년층 여성 인구의 증가에 기인합니다. 또한, 최소 침습 수술에 대한 선호도 변화, 제품 분야의 기술 발전, 제품 승인 증가 등이 시장 성장을 촉진할 것으로 예상되는 주요 요인으로 꼽힙니다.
자궁경 검사 기기 시장 역학
자궁경 검사 기기 시장은 전 세계 여성들의 부인과 질환 증가로 인해 성장세를 보이고 있습니다. 세계보건기구(WHO)(2022) 자료에 따르면, 자궁내막증은 자궁내막과 유사한 조직이 자궁 밖에서 자라는 질환으로, 전 세계 가임기 여성과 여아의 약 10%가 앓고 있습니다.
또한 GLOBOCAN(2020) 통계에 따르면 2020년 전 세계에서 새로 보고된 여성 암 환자 수는 922만 7,484명이며, 그 중 자궁경부암은 6.5%인 60만 4,127명이었습니다.
또한, 고령화 추세에 따른 여성들의 부담 증가도 향후 몇 년 동안 자궁경 검사기기 시장을 급성장시킬 요인 중 하나입니다. 고령 여성은 생식기 탈출, 폐경 후 출혈 등 다양한 부인과 질환에 걸리기 쉽기 때문입니다. 예를 들어, World Population Ageing 2020 highlights에 따르면 전 세계 65세 이상 인구는 약 7억 2,700만 명이며, 여성이 65세 이상 세계 인구의 약 55%를 차지하고 있습니다.
또한, 다양한 첨단 자궁경 검사 기기의 제품 승인 증가는 예측 기간 동안 자궁경 검사 기기 시장을 빠르게 성장시킬 것으로 예상됩니다. 예를 들어, Karl Storz SE & Co.KG는 2020년 7월 요관 및 상부 요로 등에 무균 관류액을 주입하는 자궁경용 송풍기 'Endomat Select'에 대한 FDA 승인을 획득했습니다.
또한 2020년 1월, LiNA Medical ApS는 부인과 진단 및 치료 중 자궁경부 및 자궁강을 시각화하기 위한 자궁경 'LiNA OperaScope'의 FDA 승인을 획득했습니다.
따라서, 위의 모든 요인은 예측 기간 동안 세계 자궁경 검사 기기 시장을 빠르게 성장시킬 것으로 예상됩니다.
그러나 자궁경으로 인한 감염 위험과 자궁경 검사 기기의 엄격한 규제 승인 절차는 자궁경 검사 기기 시장을 억제하는 요인이 될 가능성이 높습니다.
또한, 자궁경 검사 기기 시장은 COVID-19 팬데믹 기간 동안 성장이 둔화되었습니다. 이는 팬데믹으로 인해 전 세계 보건 비상사태가 발생하여 사회적 거리두기를 강요하고 발병을 관리하기 위해 병원 자원을 보존하기 위해 불필요한 진료를 중단했기 때문입니다. 또한, 전염병 기간 동안 선택적 수술을 중단하고 감염 확산을 억제하기 위해 세계 각국 정부가 엄격한 지침을 시행한 것도 자궁경 검사 기기 시장의 성장세를 둔화시켰습니다. 그러나 다양한 백신의 출시와 집단 예방접종 추진은 팬데믹 이후 자궁경 검사 시장이 정상화되는 데 도움이 될 것으로 예상됩니다.
자궁경 검사 기기 시장 부문별 분석
자궁경 검사 기기 제품 부문에서 경성 자궁경과 연성 자궁경 하위 범주를 가진 자궁경 부문은 향후 몇 년 동안 큰 시장 점유율을 차지할 것으로 예상됩니다. 연성 자궁경 검사는 다양한 장점으로 인해 경성 자궁경보다 선호되고 있습니다. 예를 들어, 직경이 작은 연성 자궁경 검사는 여러 연구에서 표준 경성 자궁경보다 몇 가지 이점을 보여주었습니다. 자궁 경관과 힘줄을 확장 할 필요가 없기 때문에 덜 침습적입니다. 따라서 이러한 특징은 고통이 적다는 것과 관련이 있습니다.
또한, 최신 연성 자궁경 검사 기기는 눈에 띄게 개선되었습니다. 새로운 광섬유, 비디오 시스템, 카메라 및 조명은 시스템의 품질을 향상시킵니다.
이 보고서는 세계 자궁경 검사기기 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등을 전해드립니다.
Hysteroscopy Devices Market By Product Type (Hysteroscopes [Rigid Hysteroscopes And Flexible Hysteroscopes], Hand-Held Instruments [Forceps, Scissors, Dilators, Others], Hysteroscopic Fluid Management Systems, Hysteroscopic Tissue Removal Systems, Hystero-Resectoscopes, Others), By Usability (Reusable Instruments And Disposable Instruments), By Application (Diagnostic Hysteroscopy And Operative Hysteroscopy [Myomectomy, Polypectomy, Endometrial Ablation, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), by geography, is anticipated to expand at a noteworthy CAGR forecast till 2030 due to the growing prevalence of gynaecological disorders and rising adoption rate of minimally invasive surgeries.
The global hysteroscopy devices market was valued at USD 1.29 billion in 2023, growing at a CAGR of 7.40% during the forecast period from 2024 to 2030, to reach USD 2.13 billion by 2030. The increase in demand for hysteroscopy devices is predominantly attributed to the rising geriatric women population across the globe coupled with growing cases of gynecological disorders. In addition, shifting preferences towards minimally invasive surgeries, technological advancements in the product arena, and rising product approvals, among others, are some of the key factors which is expected to drive the growth of the global hysteroscopy devices market.
Hysteroscopy Devices Market Dynamics:
The market for hysteroscopy devices is gaining momentum at present owing to the rise in gynecological disorders among women across the globe. As per the World Health Organization (WHO) 2022 data, Endometriosis, a disease where tissue similar to the lining of the uterus grows outside the uterus affects roughly 10% (190 million) of reproductive age women and girls globally.
Moreover, according to the GLOBOCAN 2020 statistics, a total of 9,227,484 new cancer cases were reported among females, worldwide in the year 2020, out of which 6.5% or 604,127 were suffering from cervix uteri cancer.
In addition, the escalating burden of the women population tending towards old age is also another factor that could surge the market for hysteroscopy devices in the upcoming years. This is because old women are more susceptible to developing various gynecological disorders such as genital prolapse, postmenopausal bleeding, and others. For instance, according to the World Population Ageing 2020 highlights, there were approximately 727 million population aged 65 years or over, worldwide and women accounted for about 55% of the global population aged 65 years or over.
Furthermore, rising product approval of various advanced hysteroscopy devices is also anticipated to spike the market for hysteroscopy devices during the forecasted period. For instance, in July 2020, Karl Storz SE & Co. KG received FDA clearance for its Endomat Select, a hysteroscopy insufflator to provide the infusion of the sterile irrigant solutions into the ureter and upper urinary tract, and others.
Also, in January 2020, LiNA Medical ApS received FDA approval for LiNA OperaScope, a hysteroscope intended for use in the visualization of the cervical canal and uterine cavity during diagnostic and therapeutic gynecological procedures.
Thus, all the above-mentioned factors are expected to surge the global market for hysteroscopy devices during the forecasted period.
However, the risk of infection from hysteroscopes and stringent regulatory approval process for hysteroscopy devices is likely to impede the hysteroscopy devices market.
Further, the market for hysteroscopy devices witnessed slow growth during the COVID-19 pandemic. This is because the pandemic has caused a global health emergency, enforcing social distancing and preserving hospital resources for the management of the outbreak thus suspending nonessential medical visits. In addition, halt in elective surgical procedures during the pandemic, implementation of stringent guidelines by the national governments across the globe to curb the transmission of the infection also slowed down the hysteroscopy devices market. However, the launch of various vaccines and mass vaccination drives will help in regaining normalcy to the hysteroscopy market during the post-pandemic period.
Hysteroscopy Devices Market Segment Analysis:
Hysteroscopy Devices Market By Product Type (Hysteroscopes [Rigid Hysteroscopes and Flexible Hysteroscopes], Hand-Held Instruments [Forceps, Scissors, Dilators, Others], Hysteroscopic Fluid Management Systems, Hysteroscopic Tissue Removal Systems, Hystero-Resectoscopes, Others), By Usability (Reusable Instruments and Disposable Instruments), By Application (Diagnostic Hysteroscopy and Operative Hysteroscopy [Myomectomy, Polypectomy, Endometrial Ablation, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Hysteroscopy Devices product segment, the hysteroscopes segment which is further subcategorized into rigid and flexible hysteroscopes is expected to hold a significant market share in the forthcoming years. The flexible hysteroscope is preferred over rigid hysteroscope due to various advantages associated with it. For instance, flexible hysteroscopes with smaller diameters have shown some advantages over standard rigid hysteroscopes in some studies. They are less invasive because there is no requirement for the dilation of the cervix or tendons. Thus, these features are associated with less pain.
Moreover, the latest flexible hysteroscopy equipment has been significantly improved. New fiber optics, video systems, cameras, and lighting have improved the quality of the systems.
For instance, in March 2019, Hologic received a CE mark for its Omni hysteroscope, a three-in-one modular scope with visualization capabilities designed for both diagnostic and therapeutic hysteroscopy procedures. The reusable rod lens of the hysteroscope utilizes rod lenses for visualization and fibers for illumination.
Hence, all the aforementioned factors are projected to contribute to the segmental growth of the global hysteroscopy devices market in the upcoming years.
North America is expected to dominate the Overall Hysteroscopy Devices Market:
Among all the regions, North America is expected to occupy a major share in the overall Hysteroscopy Devices market during the forthcoming years. This domination is owing to the increasing concern of gynecological and reproductive health problems among the women in the region. In addition, the rise in hysteroscopy procedures in the region, the presence of well-established reimbursement policies for hysteroscopy, and the rise in awareness about women's health, among others are also expected to bolster the market for hysteroscopy devices.
For instance, in the US, according to the American Cancer Society 2022 statistics, approximately 66,750 new cases of uterine/endometrial cancer are expected to be diagnosed in the same year.
In addition, as per the Office of the Assistant Secretary for Health (OASH) 2019 data, more than 11% of American women between 15 and 44 age were suffering from endometriosis in the same year.
Furthermore, an increase in hysteroscopy procedures in the country will also contribute to the market growth of hysteroscopy devices. For instance, as per the data revealed by the Center for Menstrual Disorders 2022, in the year 2017, there were over 500,000 hysteroscopic endometrial ablations performed in the United States per year. The center has performed nearly 3500 major operative hysteroscopy procedures till January 2018.
Moreover, the presence of key manufacturers in the region such as Medtronic, Hologic, CooperSurgical, and Stryker, among others, and various product approvals belonging to hysteroscopy procedures are anticipated to spike the market for hysteroscopy devices in the region. For instance, recently on September 25, 2020, Stryker received FDA clearance for various versions of Reprocessed MyoSure Tissue Removal Devices to hysteroscopically resect and remove tissue such as submucous myomas, endometrial polyps, and retained products of conception.
Thus, all the above-stated factors are expected to propel the hysteroscopy devices market in the region.
Further, the Asia-pacific region has future potential for the hysteroscopy devices market. The increasing old-age female population is the key driving factor. For instance, according to the United Nations Population Fund 2022 statistics, the number of older people in the Asia-Pacific will triple reaching 1.3 billion by 2050 where women constitute the majority (53%) of the population aged 60 or older in the region. It is also estimated that their share will rise to 60% for ages above 80 years. Additionally, the rising burden of gynecological disorders, presence of regional as well as global leaders active in manufacturing hysteroscopy devices such as Olympus and Advin Health Care, among others in the region is likely to contribute to the market growth during the forecasted period.
Hysteroscopy Devices Market Key Players:
Some of the key market players operating in the Hysteroscopy Devices market include Medtronic, Olympus, Stryker, Hologic, Boston Scientific Corporation, KARL STORZ, Richard Wolf GmbH., Advin Health Care, Ethicon (Johnson & Johnson), MEDGYN PRODUCTS, INC., CooperSurgical Inc., Cook, Maxer Endoscopy GmbH, Meditrina, Inc., XION, EMOS Technology GmbH, LUMINELLE® (UVision360), LiNA Medical ApS, RUDOLF Medical GmbH + Co. KG, Ackermann, among others.
Recent Developmental Activities in the Hysteroscopy Devices Market:
In October 2022, Hologic launched its expanded gynecological surgical offering, Omni suite, in Europe, Africa, and the Middle East (EMEA). The expanded offering currently includes a versatile Omni 30° hysteroscope, the Omni Lok cervical seal, and the Omni 5 French seal.
In January 2022, Hologic launched Fluent® Fluid Management System for hysteroscopic procedures in Europe.
In May 2020, Olympus signed an exclusive agreement with UVision360, Inc. to distribute the LUMINELLE® DTx Hysteroscopy System in the U.S.
Key Takeaways from the Hysteroscopy Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Hysteroscopy Devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Hysteroscopy Devices Market.
Various opportunities available for the other competitor in the Hysteroscopy Devices Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Hysteroscopy Devices market growth in the coming future?
Target Audience who can be benefited from the Hysteroscopy Devices Market Report Study
Hysteroscopy Devices providers
Research organizations and consulting companies
Hysteroscopy Devices-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Hysteroscopy Devices
Various End-users who want to know more about the Hysteroscopy Devices Market and latest technological developments in the Hysteroscopy Devices market.
Frequently Asked Questions for the Hysteroscopy Devices Market:
Hysteroscopy is a procedure that allows a healthcare professional to look inside the uterus to diagnose and treat the causes of various gynecological disorders. The medical devices used during the procedure are in general known as hysteroscopy devices and mainly include hysteroscopes, hysteroscopy fluid management systems, hysteroscopy dilators, and others.
The global hysteroscopy devices market was valued at USD 1.29 billion in 2023, growing at a CAGR of 7.40% during the forecast period from 2024 to 2030, to reach USD 2.13 billion by 2030.
The major factors driving the demand for Hysteroscopy Devices are the growing geriatric women population across the globe coupled with growing cases of gynecological disorders. Furthermore, shifting preferences towards minimally invasive surgeries, technological advancements in the product arena, and rising product approvals, among others, are also expected to drive the growth of the global hysteroscopic devices market.
Some of the key market players operating in the Hysteroscopy Devices market include Medtronic, Olympus, Stryker, Hologic, Boston Scientific Corporation, KARL STORZ, Richard Wolf GmbH., Advin Health Care, Ethicon (Johnson & Johnson), MEDGYN PRODUCTS, INC., CooperSurgical Inc., Cook, Maxer Endoscopy GmbH, Meditrina, Inc., XION, EMOS Technology GmbH, LUMINELLE® (UVision360), LiNA Medical ApS, RUDOLF Medical GmbH + Co. KG, Ackermann, among others.
Among all the regions, North America is expected to occupy a major share in the overall Hysteroscopy Devices market during the forecasted period, 2024-2030. This domination is owing to the rapidly increasing concern of gynecological and reproductive health problems among the female in the region. Also, the rise in hysteroscopic procedures in the region, the presence of well-established reimbursement policies for hysteroscopy, and the growing awareness about women's health, among others are expected to bolster the market for hysteroscopic devices.